CD4 and influenza: The combined use of these CTL epitope peptides, common to influenza viruses, and the surface-linked liposomal antigens which induce long-lived memory CD8+ T cells without CD4+ T cell help, was demonstrated to be applicable for the development of a CTL-based influenza vaccine that is capable of inducing protection against heterosubtypic influenza viruses [42].